August 2023 CEO Member Update

NEW: Catch up with a topline report from CRN's September Board of Directors meeting.

The CRN team has been busy this summer addressing several issues on behalf of members. President & CEO Steve Mister shares quick update on these, captured in the following short videos:

PART 1

• FDA Commissioner Robert Califf's blog about dietary supplements under the proposed agency reorganization and the CRN team's call with agency officials
• FDA's Master Files Guidance
• Congressional questions on cannabidiol (CBD) 

PART 2

• CRN's response to the U.S. Government Accountability Office on prenatal supplements
• FDA Commissioner Califf speaking during CRN's Now New Next

PART 1

PART 2

CRN 2023 Q2: How CRN has strengthened the dietary supplement and functional food industry by advancing our board-driven program of work